Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Web Exclusives

Moving Toward a Better Understanding of the Chronic Lymphocytic Leukemia Patient Experience
Web Exclusives — March 23, 2021
A new model of the symptoms and impacts faced by patients may lead to better clinical tools for understanding the patient experience. Read More ›

Watchful Waiting with Chronic Lymphocytic Leukemia
Web Exclusives — March 23, 2021
Patients who are in a period of active observation should feel comfortable sharing anything that seems abnormal with their healthcare provider. Read More ›

The Impact of Comorbid Health Conditions on Survival in Chronic Lymphocytic Leukemia
Web Exclusives — March 23, 2021
A greater number of comorbidities alone may not be sufficient to predict patient survival; age and stage at diagnosis must be considered as well. Read More ›

Acalabrutinib Shown to Be as Effective as Ibrutinib in Chronic Lymphocytic Leukemia with Less Atrial Fibrillation
Web Exclusives — March 23, 2021
The first phase 3 trial comparing these drugs shows that acalabrutinib has similar efficacy as ibrutinib with a lower risk of a worrisome side effect. Read More ›

CONQUER Celebrates Social Workers Everywhere
Web Exclusives — March 16, 2021
Social workers serve as “dot connectors” to help patients with cancer overcome barriers. Today, on World Social Work Day, CONQUER magazine celebrates social workers everywhere. Read More ›

COVID-19 One Year Later: What Patients with Cancer Need to Know
Web Exclusives — March 12, 2021
As we reflect on 1 year of living in a pandemic, here’s what we’ve learned about COVID-19, cancer, and the road ahead. Read More ›

Foods to Consume or Avoid When You Have Cancer
Web Exclusives — March 1, 2021
Arming yourself with a healthy diet during and after cancer treatment can optimize healing and improve your quality of life. Read More ›

The Impact of COVID-19 on Patient–Doctor Communication
Web Exclusives — February 23, 2021
Although the use of telemedicine has been increasing due to the COVID-19 pandemic, it has not completely replaced the need for in-person visits. Read More ›

Fewer Surprise Medical Bills Starting in 2022
Web Exclusives — February 23, 2021
A federal law protects consumers from receiving bills covering the balance of many out-of-network emergency medical services. Read More ›

Improved Combination Therapies May Be Coming for Patients with CLL
Web Exclusives — February 23, 2021
Combined acalabrutinib, venetoclax, and obinutuzumab have shown favorable efficacy and tolerability in untreated patients in an ongoing phase 2 study. Read More ›

Page 8 of 25